Do you have blue eyes? We talked to experts to discover curious facts about baby blues, including whether your biological family is bigger than you ever imagined.

Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Retinitis pigmentosa is a relatively rare genetic disorder (affecting 1 in 3,500 people), while age-related macular degeneration ... which allows for more natural vision." "In pre-clinical models ...

Designed for people experiencing macular degeneration—the leading cause of vision loss among people over the age of 60—the glasses mimic insect eyes, which use anywhere from dozens to ...

The company says that in pre-clinical tests performed on 30 people with macular degeneration, all of the participants experienced a reading speed increase of at least 50% when using the glasses.

“OCU200 has the potential to change the treatment landscape for DME, diabetic retinopathy (DR), and wet age-related macular degeneration (wet AMD) with its unique mechanism of action, binding th ...

Another is to surgically implant them onto the retina using a piece of synthetic or natural material, known as scaffolding ... gene therapy may displace anti-VEGF injection as the preferred form of ...

It is natural to assume that bad breath - also known as halitosis - is caused by a problem in the mouth. However, for a very significant number of individuals, their bad breath is not caused by a ...